Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma

References

• Handy RD, Von der Kammer F, Lead JR, Hassellöv M, Owen R, Crane M. The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology. 2008;17:287–314. doi:10.1007/s10646-008-0199-8
   PubMed Web of Science ®Google Scholar
• Govindaraju K, Krishnamoorthy K, Alsagaby SA, Singaravelu G, Premanathan M. Green synthesis of silver nanoparticles for selective toxicity towards cancer cells. IET Nanobiotechnol. 2015;9:325–330. doi:10.1049/iet-nbt.2015.0001
   PubMed Web of Science ®Google Scholar
• Ke Y, Al Aboody MS, Alturaiki W, et al. Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in cervical cancer cells (HeLa). Artif Cells, Nanomed Biotechnol. 2019;47:1938–1946. doi:10.1080/21691401.2019.1614017
   PubMed Web of Science ®Google Scholar
• Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43:6046–6051. doi:10.1021/es900754q
   PubMed Web of Science ®Google Scholar
• Rajeshkumar S. Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells. J Genet Eng Biotechnol. 2016;14:195–202. doi:10.1016/j.jgeb.2016.05.007
   PubMedGoogle Scholar
• Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743–750. doi:10.1007/s00204-010-0545-5
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim J-H. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int. 2013;2013. doi:10.1155/2013/535796
   PubMed Web of Science ®Google Scholar
• Premanathan M, Karthikeyan K, Jeyasubramanian K, Manivannan G. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomed Nanotechnol Biol Med. 2011;7:184–192. doi:10.1016/j.nano.2010.10.001
   PubMed Web of Science ®Google Scholar
• Alsagaby SA, Vijayakumar R, Premanathan M, et al. Transcriptomics-based characterization of the toxicity of ZnO nanoparticles against chronic myeloid leukemia cells. Int J Nanomedicine. 2020;15:7901–7921. doi:10.2147/IJN.S261636
   PubMed Web of Science ®Google Scholar
• Boroumand Moghaddam A, Moniri M, Azizi S, et al. Eco-friendly formulated zinc oxide nanoparticles: induction of cell cycle arrest and apoptosis in the MCF-7 cancer cell line. Genes. 2017;8:281. doi:10.3390/genes8100281
   PubMed Web of Science ®Google Scholar
• Cao Y, Roursgaard M, Kermanizadeh A, Loft S, Møller P. Synergistic effects of zinc oxide nanoparticles and fatty acids on toxicity to caco-2 cells. Int J Toxicol. 2015;34:67–76. doi:10.1177/1091581814560032
   PubMed Web of Science ®Google Scholar
• Akhtar MJ, Ahamed M, Kumar S, Khan MAM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 2012;7:845. doi:10.2147/IJN.S29129
   PubMed Web of Science ®Google Scholar
• Bai D-P, Zhang X-F, Zhang G-L, Huang Y-F, Gurunathan S. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells. Int J Nanomedicine. 2017;12:6521. doi:10.2147/IJN.S140071
   PubMed Web of Science ®Google Scholar
• Pandurangan M, Enkhtaivan G, Kim DH. Anticancer studies of synthesized ZnO nanoparticles against human cervical carcinoma cells. J Photochem Photobiol B. 2016;158:206–211. doi:10.1016/j.jphotobiol.2016.03.002
   PubMed Web of Science ®Google Scholar
• Bisht G, Rayamajhi S. ZnO nanoparticles: a promising anticancer agent. Nanobiomedicine. 2016;3:3–9. doi:10.5772/63437
   PubMedGoogle Scholar
• Jiang J, Pi J, Cai J. The advancing of zinc oxide nanoparticles for biomedical applications. Bioinorg Chem Appl. 2018;2018:1–18. doi:10.1155/2018/1062562
   Web of Science ®Google Scholar
• Shen C, James SA, de Jonge MD, Turney TW, Wright PFA, Feltis BN. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle–exposed human immune cells. Toxicol Sci. 2013;136:120–130. doi:10.1093/toxsci/kft187
   PubMed Web of Science ®Google Scholar
• Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:1–15. doi:10.1155/2013/942916
   Web of Science ®Google Scholar
• Lowe R, Shirley N, Bleackley M, Dolan S, Shafee T. Transcriptomics technologies. PLoS Comput Biol. 2017;13:e1005457. doi:10.1371/journal.pcbi.1005457
   PubMed Web of Science ®Google Scholar
• Alsagaby, Suliman A. “Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia.” Oncology Reviews 13.2 2019.
   PubMed Web of Science ®Google Scholar
• Alsagaby, Suliman A. “Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.” Saudi Medical Journal 40.4 2019;328–338.
   PubMed Web of Science ®Google Scholar
• Supplitt, Stanislaw, et al. “Current achievements and applications of transcriptomics in personalized cancer medicine.” International Journal of Molecular Sciences 22.3 2021;1422.
   PubMed Web of Science ®Google Scholar
• Sager, Monica, et al. “Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.” Expert Review of Molecular Diagnostics 15.12 2015;1589–1603.
   PubMed Web of Science ®Google Scholar
• Hanagata N, Xu M, Takemura T, Zhuang F. Cellular response to ZnO nanoparticle toxicity inferred from global gene expression profiles. Nano Biomed. 2010;2:153–169.
   Google Scholar
• Moos PJ, Olszewski K, Honeggar M, et al. Responses of human cells to ZnO nanoparticles: a gene transcription study. Metallomics. 2011;3:1199–1211. doi:10.1039/c1mt00061f
   PubMed Web of Science ®Google Scholar
• Poon W-L, Alenius H, Ndika J, et al. Nano-sized zinc oxide and silver, but not titanium dioxide, induce innate and adaptive immunity and antiviral response in differentiated THP-1 cells. Nanotoxicology. 2017;11:936–951. doi:10.1080/17435390.2017.1382600
   PubMed Web of Science ®Google Scholar
• Tuomela S, Autio R, Buerki-Thurnherr T, et al. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One. 2013;8:e68415. doi:10.1371/journal.pone.0068415
   PubMed Web of Science ®Google Scholar
• Lenz G, Staudt LM, Schwartz RS. Aggressive lymphomas. N Engl J Med. 2010;362:1417–1429. doi:10.1056/NEJMra0807082
   PubMed Web of Science ®Google Scholar
• Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:74–87. doi:10.1016/j.pathol.2017.09.006
   PubMed Web of Science ®Google Scholar
• Sehn LH, Salles G, Longo DL. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384:842–858. doi:10.1056/NEJMra2027612
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Bernard S, Meignan M, Molina T. Optimizing initial therapy in DLBCL. Best Pract Res Clin Haematol. 2018;31:199–208. doi:10.1016/j.beha.2018.08.001
   PubMed Web of Science ®Google Scholar
• Wight JC, Chong G, Grigg AP, Hawkes EA. Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Rev. 2018;32:400–415. doi:10.1016/j.blre.2018.03.005
   PubMed Web of Science ®Google Scholar
• Tweeddale ME, Lim B, Jamal N, et al. The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. Blood. 1987;69:1307–1314.
   PubMed Web of Science ®Google Scholar
• Triboulet S, Aude-Garcia C, Armand L, et al. Analysis of cellular responses of macrophages to zinc ions and zinc oxide nanoparticles: a combined targeted and proteomic approach. Nanoscale. 2014;6:6102–6114. doi:10.1039/C4NR00319E
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi:10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Reimand J, Arak T, Adler P, et al. g: profiler—a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44:W83–W9. doi:10.1093/nar/gkw199
   PubMed Web of Science ®Google Scholar
• Croce CM. Oncogenes and cancer. N Engl J Med. 2008;358:502–511. doi:10.1056/NEJMra072367
   PubMed Web of Science ®Google Scholar
• Tanaka S, Baba Y. B cell receptor signaling. In: B Cells in Immunity and Tolerance. Springer; 2020:23–36.
   Google Scholar
• Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases. Genes Dis. 2021;8:287–297. doi:10.1016/j.gendis.2020.06.005
   PubMed Web of Science ®Google Scholar
• Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11:107. doi:10.1186/s13045-018-0645-x
   PubMed Web of Science ®Google Scholar
• Zheng Y, Jiang L, Hu Y, et al. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. BMC Cancer. 2017;17:161. doi:10.1186/s12885-017-3139-2
   PubMed Web of Science ®Google Scholar
• Liu Z, Ye Q, Wu L, et al. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma. Mol Carcinog. 2018;57:1435–1444. doi:10.1002/mc.22846
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang G, Tan X, et al. MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53. Oncogenesis. 2019;8:1–11. doi:10.1038/s41389-019-0176-5
   PubMed Web of Science ®Google Scholar
• Mao J, Yu H, Wang C, et al. Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. Carcinogenesis. 2012;33:2568–2577. doi:10.1093/carcin/bgs287
   PubMed Web of Science ®Google Scholar
• Yun CW, Kim HJ, Lim JH, Lee SH. Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy. Cells. 2020;9:60. doi:10.3390/cells9010060
   Web of Science ®Google Scholar
• Chowanadisai W, Kelleher SL, Lonnerdal BO. Zinc deficiency is associated with increased brain zinc import and LIV-1 expression and decreased ZnT-1 expression in neonatal rats. J Nutr. 2005;135:1002–1007. doi:10.1093/jn/135.5.1002
   PubMed Web of Science ®Google Scholar
• García-Hevia L, Valiente R, Martín-Rodríguez R, et al. Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale. 2016;8:10963–10973. doi:10.1039/C6NR00391E
   PubMed Web of Science ®Google Scholar
• Prado F, Jimeno-González S, Reyes JC. Histone availability as a strategy to control gene expression. RNA Biol. 2017;14:281–286. doi:10.1080/15476286.2016.1189071
   PubMed Web of Science ®Google Scholar
• Hammond CM, Strømme CB, Huang H, Patel DJ, Groth A. Histone chaperone networks shaping chromatin function. Nat Rev Mol Cell Biol. 2017;18:141–158. doi:10.1038/nrm.2016.159
   PubMed Web of Science ®Google Scholar
• Kalakonda N, Fischle W, Boccuni P, et al. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene. 2008;27:4293–4304. doi:10.1038/onc.2008.67
   PubMed Web of Science ®Google Scholar
• Li N, Li Y, Lv J, et al. ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes. Mol Cell. 2016;63:470–484. doi:10.1016/j.molcel.2016.06.035
   PubMed Web of Science ®Google Scholar
• Cowger JJM, Zhao Q, Isovic M, Torchia J. Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence. Oncogene. 2007;26:3378–3386. doi:10.1038/sj.onc.1210126
   PubMed Web of Science ®Google Scholar
• Ea C-K, Hao S, Yeo KS, Baltimore D. EHMT1 protein binds to nuclear factor-κB p50 and represses gene expression. J Biol Chem. 2012;287:31207–31217. doi:10.1074/jbc.M112.365601
   PubMed Web of Science ®Google Scholar
• Mirandola L, Comi P, Cobos E, Kast WM, Chiriva-Internati M, Chiaramonte R. Notch-ing from T-cell to B-cell lymphoid malignancies. Cancer Lett. 2011;308:1–13. doi:10.1016/j.canlet.2011.05.009
   PubMed Web of Science ®Google Scholar
• Dudley DD, Wang H-C, Sun X-H. Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes. PLoS One. 2009;4:e6678. doi:10.1371/journal.pone.0006678
   PubMed Web of Science ®Google Scholar
• Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther. 2002;1:466–476. doi:10.4161/cbt.1.5.159
   PubMed Web of Science ®Google Scholar
• Fiddes IT, Lodewijk GA, Mooring M, et al. Human-specific NOTCH2NL genes affect Notch signaling and cortical neurogenesis. Cell. 2018;173:1356–69. e22. doi:10.1016/j.cell.2018.03.051
   PubMed Web of Science ®Google Scholar
• Lamar E, Deblandre G, Wettstein D, et al. Nrarp is a novel intracellular component of the Notch signaling pathway. Genes Dev. 2001;15:1885–1899. doi:10.1101/gad.908101
   PubMed Web of Science ®Google Scholar
• Song S, Johnson FB. Epigenetic mechanisms impacting aging: a focus on histone levels and telomeres. Genes. 2018;9:2–27. doi:10.3390/genes9040201
   Web of Science ®Google Scholar
• O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol. 2010;17:1218–1225. doi:10.1038/nsmb.1897
   PubMed Web of Science ®Google Scholar
• Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation. Mol Biol Rep. 2011;38:3339–3349. doi:10.1007/s11033-010-0439-x
   PubMed Web of Science ®Google Scholar
• Mishra PK, Mishra H, Ekielski A, Talegaonkar S, Vaidya B. Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications. Drug Discov Today. 2017;22:1825–1834. doi:10.1016/j.drudis.2017.08.006
   PubMed Web of Science ®Google Scholar
• Lee SH, Pie J-E, Kim Y-R, Lee HR, Son SW, Kim M-K. Effects of zinc oxide nanoparticles on gene expression profile in human keratinocytes. Mol Cell Toxicol. 2012;8:113–118. doi:10.1007/s13273-012-0014-8
   Web of Science ®Google Scholar
• Muthuraman P, Ramkumar K, Kim DH. Analysis of dose-dependent effect of zinc oxide nanoparticles on the oxidative stress and antioxidant enzyme activity in adipocytes. Appl Biochem Biotechnol. 2014;174:2851–2863. doi:10.1007/s12010-014-1231-5
   PubMed Web of Science ®Google Scholar
• Syama S, Reshma SC, Sreekanth PJ, Varma HK, Mohanan PV. Effect of zinc oxide nanoparticles on cellular oxidative stress and antioxidant defense mechanisms in mouse liver. Toxicol Environ Chem. 2013;95:495–503. doi:10.1080/02772248.2013.789606
   Web of Science ®Google Scholar
• Zhou Y, Wang L, Ban X, et al. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma. Oncogene. 2018;37:1086–1094. doi:10.1038/onc.2017.383
   PubMed Web of Science ®Google Scholar
• Jaramillo-Gutierrez G, Molina-Cruz A, Kumar S, Barillas-Mury C. The Anopheles gambiae oxidation resistance 1 (OXR1) gene regulates expression of enzymes that detoxify reactive oxygen species. PLoS One. 2010;5:e11168. doi:10.1371/journal.pone.0011168
   PubMed Web of Science ®Google Scholar
• Ding C, Fan X, Wu G. Peroxiredoxin 1–an antioxidant enzyme in cancer. J Cell Mol Med. 2017;21:193–202. doi:10.1111/jcmm.12955
   PubMed Web of Science ®Google Scholar
• Drevet JR. The antioxidant glutathione peroxidase family and spermatozoa: a complex story. Mol Cell Endocrinol. 2006;250:70–79. doi:10.1016/j.mce.2005.12.027
   PubMed Web of Science ®Google Scholar
• Hanschmann E-M, Godoy JR, Berndt C, Hudemann C, Lillig CH. Thioredoxins, glutaredoxins, and peroxiredoxins—molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal. 2013;19:1539–1605. doi:10.1089/ars.2012.4599
   PubMed Web of Science ®Google Scholar
• Danovi D, Meulmeester E, Pasini D, et al. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol. 2004;24:5835–5843. doi:10.1128/MCB.24.13.5835-5843.2004
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang Z, Li M, et al. Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene. 2007;26:5029–5037. doi:10.1038/sj.onc.1210327
   PubMed Web of Science ®Google Scholar
• Xue L, Chu F, Cheng Y, et al. Siva-1 binds to and inhibits BCL-XL-mediated protection against UV radiation-induced apoptosis. Proc Natl Acad Sci. 2002;99:6925–6930. doi:10.1073/pnas.102182299
   PubMed Web of Science ®Google Scholar
• Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351:41–58. doi:10.1007/s11010-010-0709-x
   PubMed Web of Science ®Google Scholar
• Tian H-K, Xia T, Jiang C-S, Zhang H-M, Wang K, Li X-J. TFAR19 enhances the opening of permeability transition pore in the mitochondrial membrane of mice liver. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002;34:279–284.
   PubMedGoogle Scholar
• Karl I, Jossberger-Werner M, Schmidt N, et al. TRAF2 inhibits TRAIL-and CD95L-induced apoptosis and necroptosis. Cell Death Dis. 2014;5:e1444–e. doi:10.1038/cddis.2014.404
   PubMed Web of Science ®Google Scholar
• Jiang Y, Woronicz JD, Liu W, Goeddel DV. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 1999;283:543–546. doi:10.1126/science.283.5401.543
   PubMed Web of Science ®Google Scholar
• Hitoshi Y, Lorens J, Kitada S-I, et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 1998;8:461–471. doi:10.1016/S1074-7613(00)80551-8
   PubMed Web of Science ®Google Scholar
• Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 1997;89:1067–1076. doi:10.1016/S0092-8674(00)80294-9
   PubMed Web of Science ®Google Scholar
• Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K, Yonehara S. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature. 1999;398:777–785. doi:10.1038/19709
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300–304. doi:10.1038/40901
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001;8:613–621. doi:10.1016/S1097-2765(01)00341-0
   PubMed Web of Science ®Google Scholar
• Maier JKX, Lahoua Z, Gendron NH, et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci. 2002;22:2035–2043. doi:10.1523/JNEUROSCI.22-06-02035.2002
   PubMed Web of Science ®Google Scholar
• Stegh AH, Kesari S, Mahoney JE, et al. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci. 2008;105:10703–10708. doi:10.1073/pnas.0712034105
   PubMed Web of Science ®Google Scholar
• Cazzaniga G, Tosi S, Aloisi A, et al. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with at (1; 12)(q25; p13): molecular cloning of both reciprocal transcripts. Blood. 1999;94:4370–4373. doi:10.1182/blood.V94.12.4370
   PubMed Web of Science ®Google Scholar
• Aventin A, Mecucci C, Guanyabens C, et al. Variant t (2; 18) translocation in a Burkitt conversion of follicular lymphoma. Br J Haematol. 1990;74:367–369. doi:10.1111/j.1365-2141.1990.tb02599.x
   PubMed Web of Science ®Google Scholar
• De Vos S, Hofmann W-K, Grogan TM, et al. Gene expression profile of serial samples of transformed B-cell lymphomas. Lab Invest. 2003;83:271–285. doi:10.1097/01.LAB.0000053913.85892.E9
   PubMed Web of Science ®Google Scholar
• Aggarwal M, Villuendas R, Gomez G, et al. TCL1A expression delineates biological and clinical variability in B-cell lymphoma. Mod Pathol. 2009;22:206–215. doi:10.1038/modpathol.2008.148
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Palamarchuk A, Maximov V, et al. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci. 2008;105:19643–19648. doi:10.1073/pnas.0810965105
   PubMed Web of Science ®Google Scholar
• Uddin S, Hussain AR, Siraj AK, et al. Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood. 2006;108:4178–4186. doi:10.1182/blood-2006-04-016907
   PubMed Web of Science ®Google Scholar
• Wang J, Xu-Monette ZY, Jabbar KJ, et al. AKT hyperactivation and the potential of AKT-targeted therapy in diffuse large B-cell lymphoma. Am J Pathol. 2017;187:1700–1716. doi:10.1016/j.ajpath.2017.04.009
   PubMed Web of Science ®Google Scholar
• Young RM, Shaffer Iii AL, Phelan JD, Staudt LM. B-cell receptor signaling in diffuse large B-cell lymphoma. Semin Hematol. 2015;52:77–85. doi:10.1053/j.seminhematol.2015.01.008
   PubMed Web of Science ®Google Scholar
• Niemann CU, Wiestner A. B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol. 2013;23:410–421. doi:10.1016/j.semcancer.2013.09.001
   PubMed Web of Science ®Google Scholar
• Koehrer S, Burger JA. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies. Clin Adv Hematol Oncol. 2016;14:55–65.
   PubMed Web of Science ®Google Scholar
• Kim H-O. Development of BTK inhibitors for the treatment of B-cell malignancies. Arch Pharm Res. 2019;42:171–181. doi:10.1007/s12272-019-01124-1
   PubMed Web of Science ®Google Scholar
• Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature. 2009;459:717–721. doi:10.1038/nature07968
   PubMed Web of Science ®Google Scholar
• Pavan A, Spina M, Canzonieri V, Sansonno S, Toffoli G, De Re V. Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-κB pathway as a target for new therapeutic strategies. Leuk Lymphoma. 2008;49:2048–2058. doi:10.1080/10428190802444176
   PubMed Web of Science ®Google Scholar